文献速递血管炎

模拟巨细胞动脉炎且后果严重的患者:一项长期单中心起始队列研究

Giant cell arteritis mimics with severe consequences: a long-term monocentric inception cohort.
PubMed 文献 · Rheumatology (Oxford) · 2025-01-01

该单中心回顾性研究纳入2005至2023年因初始怀疑巨细胞动脉炎(GCA)而接受颞动脉活检(TAB)的579例患者,分为TAB阳性GCA、TAB阴性GCA、无严重后果的快速替代诊断(通常模拟者)及有严重后果的替代诊断(凶险模拟者)四组。19例凶险模拟者中9例因诊断延迟出现严重结局、12例因糖皮质激素治疗出现严重副作用,平均诊断延迟145天,死亡率68%。作者认为分类标准常无法区分模拟者与真正GCA,临床警惕性、组织学证据和影像工具对排除GCA至关重要。

要点

  • 579例因怀疑GCA行TAB的患者中,19例(占所有模拟者的10%)为有严重后果的凶险模拟者。
  • 凶险模拟者平均诊断延迟145天,远长于其他组,死亡率高达68%。
  • 凶险模拟者ACR/EULAR 2022评分高于通常模拟者(6.9 vs 4.5),但与TAB阴性GCA患者相似。

核心结论

  • 误诊GCA在少数患者中可造成严重后果。
  • 分类标准常无法区分模拟者与真正GCA。
  • 临床警惕性、组织学证据和影像工具对排除GCA至关重要,应更广泛使用。
  • 减少诊断延迟对改善严重模拟者生存至关重要。

研究设计与样本

  • 单中心回顾性研究,纳入2005至2023年因初始怀疑GCA而接受颞动脉活检(TAB)的全部患者(n=579)。
  • 定义四组:TAB阳性GCA(n=248)、TAB阴性GCA(n=135)、无严重后果的快速替代诊断(通常模拟者,n=177)、有严重后果的替代诊断(凶险模拟者,n=19)。

主要发现

  • 19例凶险模拟者占所有模拟者的10%,其中9例因重大诊断延迟导致严重结局,12例因糖皮质激素治疗出现严重副作用。
  • 凶险模拟者ACR/EULAR 2022评分高于通常模拟者(6.9 vs 4.5),但与TAB阴性GCA患者评分相似。
  • 凶险模拟者平均获得替代诊断时间为66天,平均诊断延迟145天,远长于其他组。
  • 凶险模拟者死亡率高达68%。

关键数值与推荐

  • 凶险模拟者ACR/EULAR 2022评分为6.9,通常模拟者为4.5。
  • 凶险模拟者平均诊断延迟145天,平均获得替代诊断时间66天。
  • 凶险模拟者死亡率68%,19例中9例有重大诊断延迟导致的严重结局、12例有糖皮质激素治疗的严重副作用。

临床怎么用

  • 作者认为临床警惕性、组织学证据和影像工具对排除GCA至关重要,应更广泛使用。
  • 作者认为减少诊断延迟对改善严重模拟者生存至关重要。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To describe patients who underwent a temporal artery biopsy (TAB) for suspected GCA but were given a different diagnosis. We focused on a subset of alternate diagnoses mimicking GCA with ominous consequences of a delayed diagnosis or undue glucocorticoid treatment. METHODS: This was a single-centre retrospective study. All patients (n = 579) underwent a TAB for initially suspected GCA and were recruited from 2005 to 2023. Four groups were defined: GCA with a positive TAB (n = 248); GCA with a negative TAB (n = 135); rapid alternative diagnoses without ominous consequences (usual mimics, n = 177); and alternative diagnoses with severe consequences (ominous mimics, n = 19). RESULTS: Of the 19 ominous mimics (10% of all mimics), 9 had major diagnostic delays leading to severe outcomes and 12 patients suffered severe side effects from glucocorticoid treatment. The ominous mimics had higher ACR/EULAR 2022 scores than the usual mimics (6.9 vs 4.5), but they had scores similar to those with GCA and a negative TAB. The mean time to an alternative diagnosis was 66 days for the ominous mimics, and the average diagnostic delay of 145 days was much longer than that in the other groups, with a high mortality rate of 68%. CONCLUSION: Misdiagnosing GCA has severe consequences in a few patients. Classification criteria often fail to differentiate mimics from true GCA. Clinician vigilance, histology proof and imaging tools are critical for ruling out GCA and should be used more widely. Reducing diagnostic delay is essential for improving patient survival in severe mimics cases.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Parreau S, Cayrou C, Dumonteil S, et al. Giant cell arteritis mimics with severe consequences: a long-term monocentric inception cohort. Rheumatology (Oxford). 2025. PMID: 39951322. doi:10.1093/rheumatology/keaf049

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。